Cargando…
The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis
Autores principales: | Salmon, Kristiana, Ross, Jay P., Bertone, Vanessa, Gobbo, Maria, Anoja, Nancy, Karamchandani, Jason, Dion, Patrick A., Rouleau, Guy A., Genge, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626461/ https://www.ncbi.nlm.nih.gov/pubmed/35864146 http://dx.doi.org/10.1038/s41431-022-01146-2 |
Ejemplares similares
-
ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and
contribute to TDP-43 mislocalization
por: Tazelaar, Gijs H P, et al.
Publicado: (2020) -
Co‐occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades
por: Wu, Chao, et al.
Publicado: (2019) -
Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in Africans
por: Nel, Melissa, et al.
Publicado: (2021) -
Parkinson’s disease associated with pure ATXN10 repeat expansion
por: Schüle, Birgitt, et al.
Publicado: (2017) -
Questioning the Association of the STMN2 Dinucleotide Repeat With Amyotrophic Lateral Sclerosis
por: Ross, Jay P., et al.
Publicado: (2022)